Home / Business and Economy / Gujarat Kidney IPO Secures ₹100 Cr Anchor Funding
Gujarat Kidney IPO Secures ₹100 Cr Anchor Funding
20 Dec
Summary
- Gujarat Kidney raised over ₹100 crore from anchor investors.
- The company's IPO aims to raise ₹251 crore for expansion.
- Funds will support hospital acquisitions and new facilities.
Gujarat Kidney and Super Speciality has secured a significant Rs 100.01 crore from anchor investors prior to its upcoming Initial Public Offering (IPO). The healthcare provider will open its Rs 251 crore IPO for public subscription on December 22, 2025, and close on December 24, 2025, with a price band set at Rs 108-114 per equity share. This substantial anchor investment signals strong confidence from institutional players before the public offering.
The company plans to utilize the proceeds from the IPO for strategic expansions. Key investments include the acquisition of Parekhs Hospital in Ahmedabad and contributing to the purchase of Ashwini Medical Centre. Additionally, funds will support the development of a new hospital in Vadodara, equipping it with advanced robotics, alongside debt reduction and general corporate purposes.
Gujarat Kidney and Super Speciality operates seven multi-speciality hospitals across central Gujarat, offering secondary and tertiary care with a total of 490 beds. For the fiscal year ended March 2025, the company reported revenues of Rs 40.24 crore and a net profit of Rs 9.5 crore. The shares are slated for listing on both the BSE and NSE.
